ProQuad is a combination vaccine that protects children against four diseases in a single shot: measles, mumps, rubella, and varicella (chickenpox). Made by Merck, it’s FDA-approved for children ages 12 months through 12 years. By combining what would otherwise be two separate vaccines (MMR and chickenpox), ProQuad means one fewer injection at each visit.
What ProQuad Protects Against
Each dose of ProQuad contains live but weakened versions of four viruses. The measles component uses the Edmonston strain, the mumps component uses the Jeryl Lynn strain, the rubella component uses the Wistar RA 27/3 strain, and the varicella component uses the Oka/Merck strain. Because these viruses are alive but attenuated, they trigger a strong immune response without causing the actual diseases in healthy children.
A real-world study in Italy’s Veneto region found that a single dose of ProQuad was 94% effective at preventing varicella. Two doses push protection even higher, with better immune response rates against both mild and severe disease. For measles, mumps, and rubella, the vaccine uses the same proven viral strains found in the standard MMR vaccine, which has decades of established effectiveness.
Recommended Schedule
The CDC recommends ProQuad on a two-dose schedule:
- First dose: 12 through 15 months of age
- Second dose: 4 through 6 years of age
Children outside the 12-month to 12-year window are not eligible for ProQuad. Teens and adults who need protection against these diseases receive the MMR and varicella vaccines as separate shots instead.
How It’s Given
ProQuad is a 0.5 mL injection that can be given either subcutaneously (into the fatty tissue just under the skin) or intramuscularly (into the muscle). For toddlers, the typical injection site is the outer thigh. For children ages 3 and older, the upper arm is the preferred location. The vaccine comes as a powder that gets mixed with a liquid right before the injection.
Common Side Effects
The most common reaction is fever, which occurs in roughly 1 in 5 children within the first six weeks after the first dose. Most fevers are mild. In clinical trials, only about 0.8% of children developed a higher fever of 102.2°F or above in the first five days.
Redness at the injection site is also common, showing up in about 16% of children after the first dose. A small percentage of children, around 3%, develop a rash after the second dose. A measles-like rash with spots is rare and was reported in under 1% of vaccinated children in clinical studies. Side effects after the second dose tend to be milder than after the first, since the immune system is already partially primed.
Who Should Not Get ProQuad
Because ProQuad contains live viruses, it’s not appropriate for every child. The vaccine should not be given to children who:
- Have a weakened immune system due to a medical condition or medication that suppresses immune function
- Are allergic to vaccine components, including gelatin or neomycin (an antibiotic sometimes used in vaccine production)
- Had a serious reaction to a previous dose of ProQuad, MMR, or chickenpox vaccine
- Have a fever above 101.3°F at the time of the scheduled vaccination
- Have active, untreated tuberculosis
Children with a current moderate or severe illness typically wait until they recover before getting vaccinated. A mild cold or low-grade illness is generally not a reason to delay.
ProQuad vs. Separate MMR and Varicella Shots
ProQuad and its individual components (the MMR vaccine plus a standalone chickenpox vaccine) provide equivalent protection. The main advantage of ProQuad is convenience: one injection instead of two at each visit. This can be meaningful for young children and parents who want to minimize the number of shots.
One consideration is that studies have shown a slightly higher rate of fever-related seizures (called febrile seizures) after the first dose of ProQuad compared to giving MMR and varicella vaccines separately in children 12 to 23 months old. These seizures, while frightening to witness, are brief and do not cause lasting harm. Some pediatricians discuss this with parents and let them choose between the combination vaccine and two separate injections for the first dose.
For the second dose at ages 4 through 6, there is no meaningful difference in febrile seizure risk between ProQuad and separate vaccines, making the combination shot a straightforward choice at that age.